We are live on ! Find out more
LUXA

Lux Health Tech Acquisition Corp. Class A Common Stock

Delisted

LUXA was delisted on the 28th of October, 2022.

72 hedge funds and large institutions have $301M invested in Lux Health Tech Acquisition Corp. Class A Common Stock in 2022 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more funds holding

Funds holding: 7172 (+1)

8% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 12

4% more capital invested

Capital invested by funds: $290M → $301M (+$10.9M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

20% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 15

74% less call options, than puts

Call options by funds: $101K | Put options by funds: $393K

Holders
72
Holders Change
+1
Holders Change %
+1.41%
% of All Funds
1.24%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
13
Increased
12
Reduced
15
Closed
12
Calls
$101K
Puts
$393K
Net Calls
-$292K
Net Calls Change
-$34K
Name Holding Trade Value Shares
Change
Change in
Stake
ECP
1
Empyrean Capital Partners
California
$30.1M
SC
2
Sculptor Capital
New York
$20.2M +$193K +19,428 +1%
WAM
3
Weiss Asset Management
Massachusetts
$18.1M
WH
4
Wolfswood Holdings
New York
$14.4M -$2.59M -260,000 -15%
Marshall Wace
5
Marshall Wace
United Kingdom
$13.8M
Balyasny Asset Management
6
Balyasny Asset Management
Illinois
$12.4M +$408 +41 +0%
MMA
7
Mizuho Markets Americas
New York
$12.4M +$12.4M +1,241,420 New
SCM
8
Saba Capital Management
New York
$10.3M
GCL
9
Glazer Capital LLC
New York
$9.52M +$2.17M +217,612 +30%
MA
10
MYDA Advisors
New York
$7.3M -$1.7M -171,200 -19%
GL
11
Governors Lane
New York
$7.26M
CCA
12
Castle Creek Arbitrage
Colorado
$7.15M
MTCM
13
Mint Tower Capital Management
Netherlands
$6.82M +$742K +74,551 +12%
AA
14
AQR Arbitrage
Connecticut
$6.77M
BP
15
BBR Partners
New York
$6.41M
HI
16
HBK Investments
Texas
$5.54M
Walleye Capital
17
Walleye Capital
New York
$5.45M +$5.42M +544,450 New
PAMP
18
Polar Asset Management Partners
Ontario, Canada
$5.01M
FTCM
19
Fir Tree Capital Management
New York
$4.91M -$41.5K -4,170 -0.8%
BCM
20
Beryl Capital Management
California
$4.74M +$4.71M +473,492 New
Goldman Sachs
21
Goldman Sachs
New York
$4.52M -$102K -10,210 -2%
Nomura Holdings
22
Nomura Holdings
Japan
$4.47M
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
23
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$4.38M
KKRC
24
Kohlberg Kravis Roberts & Co
New York
$4.14M
CSS
25
Cubist Systematic Strategies
Connecticut
$4.08M -$4.26M -428,455 -51%

LUXA Hedge Fund Activity: Q3 2022 in Review

72 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) for Q3 2022, worth a combined $301M — up 3.7% from $290M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new LUXA positions and 12 closed out — a net gain of 1 holder — while 12 added to existing stakes and 15 trimmed.

The largest buyer was Mizuho Markets Americas, opening a new position worth an estimated $12.4M. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $9.8M sold.

  • 72 institutional investors held Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) as of Q3 2022, up from 71 in Q2 2022.
  • Funds reported $301M of Lux Health Tech Acquisition Corp. Class A Common Stock stock for Q3 2022, up 3.7% quarter-over-quarter.
  • 13 funds opened new Lux Health Tech Acquisition Corp. Class A Common Stock positions in Q3 2022 and 12 closed out, a net change of +1 holder.
  • The largest Lux Health Tech Acquisition Corp. Class A Common Stock buyer in Q3 2022 was Mizuho Markets Americas, an estimated $12.4M added.
  • The largest Lux Health Tech Acquisition Corp. Class A Common Stock seller in Q3 2022 was D.E. Shaw & Co, an estimated $9.8M sold.

Based on aggregated 13F filings for Q3 2022.